New Drug Causes 20 Percent Weight Loss in Early Amgen Results
The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 percent of their weight in a year. The drug, MariTide, is given by injection once a month, compared with once a week for other obesity drugs like Wegovy and Zepbound that are already on the market.
Amgen on Tuesday said its weight loss drug MariTide helped people with obesity lose up to 20% of their body weight over ...
The alternative is for either investors or regulators to find out during the drug's approval process ... a previously ...
Key TakeawaysA Phase 2 study of Amgen's experimental weight-loss treatment didn't meet expectations of analysts.Concerns were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback